Soliris 300 mg/30 mL (10 mg/mL) injection Images
Generic Name: eculizumab
This medication has been identified as Soliris 300 mg/30 mL (10 mg/mL) injection. It is supplied by Alexion Pharmaceuticals Inc.
Soliris is used in the treatment of Myasthenia Gravis; Hemolytic Uremic Syndrome; Neuromyelitis Optica Spectrum Disorder; Paroxysmal Nocturnal Hemoglobinuria and belongs to the drug class selective immunosuppressants. Risk cannot be ruled out during pregnancy. Soliris 300 mg/30 mL (10 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Soliris
- Generic Name
- eculizumab
- Strength
- 300 mg/30 mL (10 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alexion Pharmaceuticals Inc.
- National Drug Code (NDC)
- 25682-0001
More about Soliris (eculizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
